Inspire Medical Systems, Inc.
INSPHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeInspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the. The $1.19B market capitalization puts INSP squarely in small-cap range for its industry. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.
Market Cap
$1.19B
Beta
0.83
P/E (TTM)
9.40
P/E (Fwd)
31.69
EPS (TTM)
$4.40
EPS (Fwd)
$1.31
ROE
18.4%
ROA
3.9%
Cash
$283.8M
Total Debt
$29.6M
Free CF
$85.6M
52W Change
-69.1%
Annual Financials
Cash vs Debt
With $283.8M in cash and $29.6M in debt, INSP maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Annual free cash flow of $85.6M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 18.4% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $407.9M (2022) to $912.0M (2025), reflecting a 124% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Inspire Medical Systems, Inc. and its sector.